WARNING: THROMBOSIS, RENAL DYSFUNCTION, and ACUTE RENAL FAILURE
Click here for full Prescribing Information

• Thrombosis may occur with immune globulin intravenous (IGIV) products, including octagam® 5% liquid. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity, and cardiovascular risk factors.
  
  
• Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur in predisposed patients with IGIV products, including octagam® 5% liquid. Renal dysfunction and acute renal failure occur more commonly with IGIV products containing sucrose. octagam® 5% liquid does not contain sucrose.

For patients at risk of thrombosis, renal dysfunction, or acute renal failure administer octagam® 5% liquid at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.